Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

1200px-vaccine_image_1_1

Americans could get coronavirus vaccine by December, according to leader of Operation Warp Speed

November 23, 2020 Sales and Marketing

Certain Americans could receive a coronavirus vaccine as early as next month, according to Dr Moncef Slaoui, Chief Scientific Adviser …
News
fda_21_4_1_0

FDA grants Emergency Use Authorization for Regeneron’s antibody treatment

November 23, 2020 Sales and Marketing

The FDA has granted Emergency Use Authorization for Regeneron’s coronavirus antibody treatment which was used to treat President Donald Trump …
News
jnjioffice_1

Johnson & Johnson set to pay $120 million in New York baby powder case

November 23, 2020 Sales and Marketing

A New York judge has ordered Johnson & Johnson to pay $120 million to a woman and her husband after …
News
fdaoutsideweb

Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today

November 20, 2020 Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …
News
influenza

First recombinant influenza vaccine approved in the European Union

November 20, 2020 Medical Communications, Sales and Marketing Europe, influenza, pharma

The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …
News

OPEN Health reveals new CEO appointment

November 19, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …
News
lilly_building_with_american_flag_web

NICE recommends Lilly’s Emgality for chronic and episodic migraine

November 18, 2020 Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK

Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …
News
moderna_norwood_plant

UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy

November 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine

US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
News
512px-ugur_sahin_01

BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year

November 16, 2020 Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …
News

J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen

November 16, 2020 Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …
News
flu_vaccination_grippe_5115654021_2

British Labour Party calls for new laws to tackle online anti-vaxx campaigns

November 16, 2020 Sales and Marketing

The British Labour Party has called for the implementation of new legal measures to combat anti-vaccination campaigns on the internet …
News
obsessive_compulsive_disorder_8970250666

Antidepressants could treat coronavirus, new study suggests

November 16, 2020 Sales and Marketing

The antidepressant fluvoxamine could treat COVID-19 patients and stop their symptoms from worsening, according to a new study. 
News
1200px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

UK Prime Minister Boris Johnson self-isolating after meeting an MP who had COVID-19

November 16, 2020 Sales and Marketing

The British Prime Minister Boris Johnson has begun working in self isolation after coming into contact with an MP who …
News
guido_rasi

Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role

November 13, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma

Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …
News

NICE recommends Sanofi’s Cablivi for ultra-rare acute thrombotic thrombocytopenic purpura

November 12, 2020 Sales and Marketing NHS, NICE, Sanofi, pharma

Sanofi’s Cablivi (caplacizumab) has received recommendation from NICE for routine NHS use in England and Wales for the treatment of …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026